课题基金 / 基金详情

Physiological and pathological functions of PQBP-1

Physiological and pathological functions of PQBP-1
PQBP-1的生理和病理功能
批准号:
12670596
负责人:
OKAZAWA Hitoshi
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

OKAZAWA Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
在本项目中,我们分析了PQBP-1的生理和病理功能,它是我们发现的一种新的与聚谷氨酰胺序列结合的蛋白。首先,我们发现PQBP-1还与SCA1的致病基因产物ataxin-1相互作用,协同诱导转录抑制。PQBP-1和ataxin-1之间的相互作用抑制了转录,不是在包涵体中,而是在核基质中,这表明了一种新的发病机制。此外,我们的研究表明,这种相互作用导致RNA聚合酶II的磷酸化形式(=活性形式)减少。这些结果与PQBP-1转基因小鼠一起,将有助于理解这种类型的神经退行性疾病。
英文摘要
In this project, we have analyzed physiological and pathological functions of PQBP-1, which we found as a novel binding protein to the polyglutamine sequences. First, we found that PQBP-1 also interacts with ataxin-1, a causative gene product of SCA1, and induces transcriptional repression cooperatively. The interaction between PQBP-1 and ataxin-1 inhibits transcription not in the inclusion body but in the nuclear matrix, suggesting a new cascade of pathogenesis. Furthermore, our study showed that the interaction leads to reduction of phosphorylated form (=active form) of RNA polymerase II. These results, together with transgenic mouse of PQBP-1, will contribute for understanding this type of neurodegenerative diseases.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Shoji M. et al.: "JNK activation is associated with intracellular β-amyloid accumulation."Molecular Brain Research. 85. 221-223 (2001)
Shoji M. 等人:“JNK 激活与细胞内 β-淀粉样蛋白积累相关。”《分子脑研究》85. 221-223 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ueda H, Goto J, Hashida H, Lin X, Oyanagi K, kawano H, et al.: "Enhanced SUMOylation in polyglutamine diseases"Biochem. Biophys. Res. Commun.. (in press).
Ueda H、Goto J、Hashida H、Lin X、Oyanagi K、kawano H 等:“多谷氨酰胺疾病中增强的 SUMO 化”Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ueda H., Goto J., Hashida H., Lin X., Oyanagi K., Kawano H., Zoghbi H.Y., Kanazawa I., and Okazawa H.: "Enhanced SUMOylation in polyglutamine diseases."Biochem. Biophys. Res. Commun.. (in press). (2002)
Ueda H.、Goto J.、Hashida H.、Lin X.、Oyanagi K.、Kawano H.、Zoghbi H.Y.、Kanazawa I. 和 Okazawa H.:“多谷氨酰胺疾病中增强的 SUMOylation。”Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Waragai M. et al.: "PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15KD/dim1p via the Carboxyl-terminal domain."Biochem.Biophys.Res.Commun.. 273. 592-595 (2000)
Waragai M. 等人:“PQBP-1/Npw38 是一种与聚谷氨酰胺束结合的核蛋白,通过羧基末端结构域与 U5-15KD/dim1p 相互作用。”Biochem.Biophys.Res.Commun.. 273. 592
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 11 条
    Drug development for polyglutamine diseases by a combined phenotype analysis system
    • 批准号:
      21390265
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2009
    • 负责人:
      OKAZAWA Hitoshi
    • 依托单位:
    Basic Research for Development of the Polyglutamine Disease Therapeutics by HMGB proteins
    • 批准号:
      18390254
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.11万
    • 财政年份:
      2006
    • 负责人:
      OKAZAWA Hitoshi
    • 依托单位:
    Basic Research for Development of Novel Therapeutics of Polyglutamine Diseases through Transcriptional Regulation
    • 批准号:
      16390249
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.17万
    • 财政年份:
      2004
    • 负责人:
      OKAZAWA Hitoshi
    • 依托单位:
    Functional and dynamic gene expression profiling of polyglutamine
    海外基金